10.26355/eurrev_202012_24046 Eur Rev Med Pharmacol Sci
According to a clinical trial published in the New England Journal of Medicine , Tesamorelin significantly reduced VAT and improved lipid profiles in patients with HIV-associated lipodystrophy (Falutz et al., 2010)
Skin elasticity using a cutometer was measured at baseline, at 4 weeks, and then 4 weeks after discontinuation of the treatment, which showed significant improvement in skin elasticity, even in sun-exposed skin areas, during these time points compared with baseline values [39]
PMID: 8 ZhangCLiuXJinSChenYGuoR
CJC-1295 DAC + Ipamorelin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use
Ekong, A., Berg, L., Amos, R